foxo4 dri human trial The disordered p53 transactivation domain is the target of and the senolytic compound FOXO4-DRI B12 Injection vs Oral Packaging:1 Each C-BYB
Pay in 4 interest-free payments of $7.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 15 - Sep 20